{
    "id": 26267,
    "fullName": "KDM5C mutant",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "KDM5C mutant indicates an unspecified mutation in the KDM5C gene.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "category",
    "gene": {
        "id": 8242,
        "geneSymbol": "KDM5C",
        "terms": [
            "KDM5C",
            "DXS1272E",
            "JARID1C",
            "MRX13",
            "MRXJ",
            "MRXSCJ",
            "MRXSJ",
            "SMCX",
            "XE169"
        ]
    },
    "variant": "mutant",
    "createDate": "04/05/2017",
    "updateDate": "04/05/2017",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 10433,
            "approvalStatus": "Phase II",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase II trial, KDM5C mutations were associated with longer first-line progression free survival (20.6 vs 8.3 months) in first-line Sutent (sunitinib)-treated renal cell carcinoma patients compared to first-line Afinitor (everolimus)-treated patients (PMID: 27751729).",
            "molecularProfile": {
                "id": 27460,
                "profileName": "KDM5C mutant"
            },
            "therapy": {
                "id": 930,
                "therapyName": "Sunitinib",
                "synonyms": null
            },
            "indication": {
                "id": 4450,
                "name": "renal cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 8445,
                    "pubMedId": 27751729,
                    "title": "Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27751729"
                }
            ],
            "ampCapAscoEvidenceLevel": "B",
            "ampCapAscoInferredTier": "I"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27460,
            "profileName": "KDM5C mutant",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}